The AHA Feb. 28 filed a friend-of-the-court brief in the U.S. District Court for the District of Columbia, urging the court to uphold the Health Resources and Services Administration鈥檚 decision to reject Johnson & Johnson鈥檚 proposed 340B rebate model in a lawsuit brought by J&J to bar the agency from doing so.

鈥淎s the Court evaluates this case, it should bear in mind what Justice Kavanaugh wrote for a unanimous Supreme Court just a few years ago: 鈥340B hospitals perform valuable services for low-income and rural communities but have to rely on limited federal funding for support,鈥欌 the AHA wrote. 鈥淛&J鈥檚 rebate policy shrinks that already-limited funding even further, endangering the care that 340B hospitals provide for their patients and communities. If J&J is dissatisfied with 340B law or policy, it can seek change in the political branches. But it cannot take the law into its own hands and then seek judicial permission for its extra-legal actions.鈥

Others joining the AHA in the Feb. 28 filing were the Children鈥檚 Hospital Association, the Association of American Medical Colleges and America鈥檚 Essential Hospitals.

Related News Articles

Headline
The AHA today filed an amicus brief in the U.S. Court of Appeals for the D.C. Circuit, defending the Department of Health and Human Services鈥 decision to鈥
Headline
The Department of Health and Human Services today issued a notice announcing a 340B Rebate Model Pilot Program as a voluntary mechanism for qualifying drug鈥
Headline
Rep. Doris Matsui, D-Calif., and Sen. Peter Welch, D-Vt., today introduced the 340B Patients Act, AHA-supported legislation that would codify 340B providers'鈥
Headline
The AHA July 16 filed an amicus brief in the U.S. District Court for the District of Colorado in defense of the state鈥檚 340B contract pharmacy law prohibiting鈥
Headline
The U.S. District Court for the Eastern District of Missouri July 11 granted a motion by the state to dismiss claims by AbbVie that the state鈥檚 340B contract鈥
Headline
The U.S. District Court for the Middle District of Tennessee June 30 denied a motion for a preliminary injunction by AbbVie in its lawsuit against the state鈥檚鈥